M. D. Cappellini Et Al. , "A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia," NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13, pp.1219-1231, 2020
Cappellini, M. D. Et Al. 2020. A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13 , 1219-1231.
Cappellini, M. D., Viprakasit, V., Taher, A. T., Georgiev, P., Kuo, K. H. M., Coates, T., ... Voskaridou, E.(2020). A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia. NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13, 1219-1231.
Cappellini, M. Et Al. "A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia," NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13, 1219-1231, 2020
Cappellini, M. D. Et Al. "A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13, pp.1219-1231, 2020
Cappellini, M. D. Et Al. (2020) . "A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia." NEW ENGLAND JOURNAL OF MEDICINE , vol.382, no.13, pp.1219-1231.
@article{article, author={M. D. Cappellini Et Al. }, title={A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia}, journal={NEW ENGLAND JOURNAL OF MEDICINE}, year=2020, pages={1219-1231} }